Frontlight ResearchEarly access
Active, not recruitingNo phase
Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN
Key facts
- Who runs it
- Fondation Ophtalmologique Adolphe de Rothschild
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 230 people enrolled
- Started
- 20 Dec 2017
- Expected to end
- 23 Jun 2033
- Type of study
- Observational
- Treatments tested
- Collection of blood sample in aneurysm
- Record updated
- 20 January 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patient aged 18 and over
- Patient presenting a single or multiple aneurysm
- Patient presenting an intracranial aneurysm for which an intervention is planned (endovascular treatment or surgery) : elective intervention for an unruptured aneurysm or emergency surgery for a broken aneurysm
Who cannot take part
- Pregnant or breast feeding woman
- Patient benefiting from legal protection measures
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Sub arachnoid hemorrhage consecutive to intracranial aneurysm rupture is a devastating disease. Predictors of intracranial aneurysm rupture are limited and focus mainly on size and location. Platelet activation may have a deleterious role on aneurysm rupture. The assumption is that patients with ruptured intracranial aneurysm will present a higher rate of platelet activation compared to patients with non ruptured aneurysms.
Treatments tested
- Collection of blood sample in aneurysm
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 20 January 2026